Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.
JOINN Biologics has raised $150.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.
JOINN Biologics's investors include Huagai Capital, Green Pine Capital Partners, CPE, Hongtai Capital Holdings, Yingke Capital.
JOINN Biologics is headquartered in Richmond, United States.
Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.
JOINN Biologics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"JOINN Biologics — Funding & Investors." VCBacked, August 1, 2021, https://www.vcbacked.co/company/joinn-biologics. Accessed August 14, 2026.
VCBacked. (2021). JOINN Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/joinn-biologics
{{cite web |title=JOINN Biologics — Funding & Investors |url=https://www.vcbacked.co/company/joinn-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated